Efficacy of Infliximab in the Treatment of Patients Affected by Corticodependent Crohn's Disease (P02732)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2003
This is a double-blind, double-dummy, prednisolone-controlled, multi-center, randomized, parallel-group clinical study to evaluate the therapeutic efficacy of repeated infliximab infusions in order to maintain Crohn\'s disease remission at the end of the study.
Epistemonikos ID: 2b94e82738833039092b0375f09549ffffad311d
First added on: May 05, 2024